Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Methamphetamine Use Disorder       
Yazarlar (5)
Bahadır Demir
Gaziantep Üniversitesi, Türkiye
Şengül Kocamer Şahin
Gaziantep Üniversitesi, Türkiye
Doç. Dr. Filiz ÖZSOY Tokat State Hospital, Türkiye
Abdurrahman Altındağ
Gaziantep Üniversitesi, Türkiye
Gülçin Elboğa
Gaziantep Üniversitesi, Türkiye
Makale Türü Açık Erişim Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale
Dergi Adı Psychiatry and Clinical Psychopharmacology
Dergi ISSN 2475-0573 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Dergi Grubu Q3
Makale Dili İngilizce
Basım Tarihi 01-2021
Cilt No 31
Sayı 1
Sayfalar 34 / 39
DOI Numarası 10.5152/pcp.2021.20156
Makale Linki 10.5152/pcp.2021.20156
Özet
Objective: Methamphetamine (METH) is a potent central nervous system (CNS) stimulant that rapidly enhances the release of neurotransmitters, including adrenaline, dopamine, and serotonin. It is also one of the most popular illicit drugs of choice worldwide known as “ice”. In this study, we examined the neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) levels in patients with methamphetamine use disorder. Materials and Methods: This study included a total of 84 patients with only methamphetamine use and 81 healthy individuals. Participants who had hematological disorders and other chronic diseases were excluded from the study. White blood cell, neutrophil, lymphocyte, and platelet count were compared between groups. NLR and PLR values were calculated and compared between groups. Results: The patient group comprised 81 males and 3 females with the mean age of 26.37 ± 5.99 years. There was no significant difference between patient and control group in terms of age, sex, BMI, smoking status, and alcohol consumption. NLR and PLR ratios were lower in the patient group than controls. NLR and PLR values were positively correlated with daily dosage of METH use (r = 0.227 P = .038, r = 0.228 P = .037, respectively). Conclusion: To the best of our knowledge, our study is the first study examining the relationship between NLR and PLR in patients with METH use disorder. NLR and PLR were found to be lower in patients with METH use disorder. The effects of METH on the immune system should be considered. Prospective, longitudinal studies involving intoxication-detoxification-remission periods are needed.
Anahtar Kelimeler
Lymphocyte | methamphetamine | neutrophil | platelet | substance